Nektar Therapeutics
NKTR
NKTR
197 hedge funds and large institutions have $2.96B invested in Nektar Therapeutics in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 99 increasing their positions, 50 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 201 → 197 (-4)
14% less capital invested
Capital invested by funds: $3.44B → $2.96B (-$477M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
197
Holding in Top 10
4
Calls
$31.7M
Puts
$10.6M
Top Buyers
| 1 | +$34.7M | |
| 2 | +$32.6M | |
| 3 | +$25M | |
| 4 |
O
OppenheimerFunds
New York
|
+$24.4M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$9.78M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$16.3M | |
| 3 | -$12.6M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$10.8M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$10.1M |